Health Care · Life Sciences Tools & Services
Danaher Corporation DHR
$203.83-1.18 (-0.58%)delayed quote · as of 2026-07-17 20:57 UTC
Market cap
$144.3B
Previous close
$205.01
Volume
3.9M
52-week range
$160.93 – $242.80
Verdictconfidence 100% · high
Health stands out; growth and momentum flash caution.
3 of 5 dimensions score well; growth and momentum flash caution.
Value603/5 checks
Growth402/5 checks
Quality603/5 checks
Health804/5 checks
Momentum402/5 checks
Fair-value estimate $231.25 per share (2-stage FCF · individual beta · 10Y Rf 4.6%) — the price sits 12% below it.
Every check behind these scores — with its numbers, source, and evidence link — is in the workspace.
Key ratioslatest filing FY 2025
Value
P/E TTM
38.9
P/E NTM
22.2
EV/EBITDA
20.0
PEG
1.28
FCF yield
3.6%
Growth
Revenue 3y
−2.7%/yr
Revenue YoY
+2.9%
Expected EPS
+75.3%
Quality
Piotroski F
5 / 9
ROIC
ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-17 20:57 UTC · fundamentals FY 2025 · SEC EDGAR
Continue with DHR in ALAN
Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.
For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.